Abstract:Eimeria maxima (E. maxima) is one of the most prevalent species that causes chicken coccidiosis on chicken farms. During apicomplexan protozoa invasion, rhomboid-like proteins (ROMs) cleave microneme proteins (MICs), allowing the parasites to fully enter the host cells, which suggests that ROMs have the potential to be candidate antigens for the development of subunit or DNA vaccines against coccidiosis. In this study, a recombinant protein of E. maxima ROM5 (rEmROM5) was expressed and purified and was used as a subunit vaccine. The eukaryotic expression plasmid of pVAX–EmROM5 was constructed and was used as a DNA vaccine. Chickens who were two weeks old were vaccinated with the rEmROM5 and pVAX–EmROM5 vaccines twice, with a one-week interval separating the vaccination periods. The transcription and expression of pVAX–EmROM5 in the injected sites were detected through reverse transcription PCR (RT-PCR) and Western blot (WB) assays. The cellular and humoral immune responses that were induced by EmROM5 were determined by detecting the proportion of CD4+ and CD8+ T lymphocytes, the cytokine levels, and the serum antibody levels. Finally, vaccination-challenge trials were conducted to evaluate the protective efficacy of EmROM5 in forms of the recombinant protein (rEmROM5) and in the DNA plasmid (pVAX–EmROM5) separately. The results showed that rEmROM5 was about 53.64 kDa, which was well purified and recognized by the His-Tag Mouse Monoclonal antibody and the chicken serum against E. maxima separately. After vaccination, pVAX–EmROM5 was successfully transcribed and expressed in the injected sites of the chickens. Vaccination with rEmROM5 or pVAX–EmROM5 significantly promoted the proportion of CD4+/CD3+ and CD8+/CD3+ T lymphocytes, the mRNA levels of the cytokines IFN-γ, IL-2, IL-4, IL-17, TNF SF15, and IL-10, and specific IgG antibody levels compared to the control groups. The immunization also significantly reduced the weight loss, oocyst production, and intestinal lesions that are caused by E. maxima infection. The anticoccidial index (ACI)s of the vaccinated groups were beyond 160, showing moderate protection against E. maxima infection. In summary, EmROM5 was able to induce a robust immune response and effective protection against E. maxima in chickens in the form of both a recombinant protein and DNA plasmid. Hence, EmROM5 could be used as a candidate antigen for DNA vaccines and subunit vaccines against avian coccidiosis.

Protective Immunity Against Eimeria Maxima Induced by Vaccines of Em14-3-3 Antigen.

Protective Efficacy of Rhomboid-Like Protein 3 as a Candidate Antigen Against <i>Eimeria maxima</i> in Chickens

Eimeria maxima microneme protein 2 delivered as DNA vaccine and recombinant protein induces immunity against experimental homogenous challenge

Protective efficacy of Eimeria maxima EmLPL and EmTregIM-1 against homologous challenge in chickens

Protective Efficacy Induced by the Common Eimeria Antigen Elongation Factor 2 against Challenge with Three Eimeria Species in Chickens

Immune protection of microneme 7 (EmMIC7) against Eimeria maxima challenge in chickens

Rhomboid Protein 2 of Eimeria Maxima Provided Partial Protection Against Infection by Homologous Species.

Protective Efficacy Induced by Eimeria Maxima Rhomboid-Like Protein 1 Against Homologous Infection

An <i>Eimeria maxima</i> Antigen: Its Functions on Stimulating Th1 Cytokines and Protective Efficacy Against Coccidiosis

Co-immunization with Two Recombinant Eimeria Tenella Lines Expressing Immunoprotective Antigens of E. Maxima Elicits Enhanced Protection Against E. Maxima Infection

Protective immunity induced by Eimeria common antigen 14–3-3 against Eimeria tenella, Eimeria acervulina and Eimeria maxima

Eimeria Maxima Rhomboid-like Protein 5 Provided Partial Protection Against Homologous Challenge in Forms of Recombinant Protein and DNA Plasmid in Chickens

Em14-3-3 delivered by PLGA and chitosan nanoparticles conferred improved protection in chicken against Eimeria maxima

Prokaryotic expression and antigenicity analysis of EmGAM56 protein of Eimeria maxima

Cross immunity of DNA vaccine pVAX1-cSZ2-IL-2 to Eimeria tenella, E. necatrix and E. maxima

The Molecular Characterization and Protective Efficacy of Microneme 3 of Eimeria Mitis in Chickens.

In Vitro Effects of 5 Recombinant Antigens of Eimeria Maxima on Maturation, Differentiation, and Immunogenic Functions of Dendritic Cells Derived from Chicken Spleen

A Novel Vaccine Delivery Model of the Apicomplexan Eimeria Tenella Expressing Eimeria Maxima Antigen Protects Chickens Against Infection of the Two Parasites.

Construction of Eukaryotic Expression Plasmid with Eimeria Acervulina 3-1E Gene and Its Immune Protection Efficacy Against Homologous Eimeria Challenge.

Prokaryotic Expression of Eimeria magna SAG10 and SAG11 Genes and the Preliminary Evaluation of the Effect of the Recombinant Protein on Immune Protection in Rabbits

PLGA Nanospheres As Delivery Platforms for Eimeria Mitis 1a Protein: A Novel Strategy to Improve Specific Immunity